| Current Price | $6.55 | Mkt Cap | $222.4M |
|---|---|---|---|
| Open | $6.84 | P/E Ratio | 0.00 |
| Prev. Close | $6.55 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.53 - $6.84 | Volume | 151,364 |
| 52-Wk Range | $6.20 - $13.49 | Avg. Daily Vol. | 177,408 |
| Current Price | $6.55 | Mkt Cap | $222.4M |
|---|---|---|---|
| Open | $6.84 | P/E Ratio | 0.00 |
| Prev. Close | $6.55 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.53 - $6.84 | Volume | 151,364 |
| 52-Wk Range | $6.20 - $13.49 | Avg. Daily Vol. | 177,408 |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(75.19)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-189.24
nev
Recs
treasureoaks
(21.97)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-208.30
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-211.34
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (27.70) Score: +210.61
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 27.70 | 3/20/2015 |
|
NS | $405.00 | -98.35% | +112.26% | +210.61 | 0 Comment | |
| IdahoInvestor | 27.15 | 8/17/2015 |
|
5Y | $15.75 | -57.52% | +113.53% | +171.05 | 0 Comment | |
| jon5555 | 92.41 | 9/29/2020 |
|
5Y | $8.29 | -19.30% | +33.75% | +53.05 | 0 Comment | |
| cruisin25 | 60.81 | 8/11/2021 |
|
3M | $8.44 | -20.73% | +0.41% | -21.15 | 0 Comment | |
| PAGEBOY2020 | 90.43 | 8/13/2021 |
|
5Y | $8.85 | -24.36% | +0.02% | -24.38 | 0 Comment | |
|
OneBee | 35.35 | 5/4/2021 |
|
3M | $8.67 | -22.84% | +7.10% | -29.94 | 0 Comment |
| foggs1 | 68.08 | 3/17/2021 |
|
5Y | $10.12 | -33.89% | +12.96% | -46.85 | 0 Comment | |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | +17.16% | +69.32% | -52.15 | 0 Comment | |
| odocoileus | 58.46 | 9/10/2020 |
|
5Y | $10.48 | -36.16% | +33.06% | -69.22 | 0 Comment | |
| drugtrader | 85.91 | 7/8/2020 |
|
5Y | $9.43 | -29.06% | +42.45% | -71.50 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
